{
    "title": "Merck's blood vessel disorder therapy receives US FDA's priority review (Sept. 28)",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12570723/Mercks-blood-vessel-disorder-therapy-receives-US-FDAs-priority-review.html",
    "date": "2023-09-28",
    "keywords": [
        "therapy",
        "blood",
        "pah",
        "type",
        "disorder",
        "drugmaker",
        "acceleron",
        "merck",
        "market",
        "class",
        "pressure",
        "thursday",
        "health",
        "regulator",
        "vessel",
        "priority",
        "basis",
        "acquisition",
        "pharma",
        "food",
        "drug",
        "administration",
        "target",
        "action",
        "date",
        "review",
        "revenue",
        "stream",
        "blockbuster",
        "cancer",
        "immunotherapy",
        "keytruda",
        "loss",
        "exclusivity",
        "application",
        "latestage",
        "study",
        "background",
        "hypertension",
        "treatment",
        "protein",
        "hormone",
        "disease",
        "jp",
        "analyst",
        "chris",
        "schott",
        "deal",
        "guanylate",
        "cyclase",
        "flow",
        "year",
        "government",
        "reporting",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}